Key facts
- This page summarizes Gisela Schwab's Form 4 filing for EXELIXIS, INC. (EXEL).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 28 Jul 2021, 20:06.
Gisela Schwab - 26 Jul 2021 Form 4 Insider Report for EXELIXIS, INC. (EXEL)
- Reporting relationship
- Pres, Prod Dev & Med Aff & CMO
- Issuer ticker
- EXEL
- Reported as of
- 26 Jul 2021
- Net transaction value
- +$168,000
- SEC form
- 4
- Accepted by SEC
- 28 Jul 2021, 20:06:41 UTC
- Prior SEC filing
- 23 Jul 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jennifer Drimmer Rokovich, Attorney in Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Gisela Schwab filed Form 4 for EXELIXIS, INC. (EXEL) on 28 Jul 2021.
Change
- Previous filing in this sequence was filed on 23 Jul 2021.
- Current net transaction value: +$168,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EXEL
transaction
Common Stock
Options Exercise
- Transaction value
- $168,000
- Shares
- +40,000
- Change %
- +6.2%
- Price
- $4.20*
- Shares after
- 689,078
- Date
- 26 Jul 2021
- Ownership
- Direct
- Footnotes
- F1
EXEL
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 14,880
- Date
- 26 Jul 2021
- Ownership
- By 401(k)
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
EXEL
transaction
Derivative
Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -40,000
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 26 Jul 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 40,000
- Exercise price
- $4.20
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Includes 243,968 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
Footnote F2
Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of July 23, 2021.
Footnote F3
The option, representing the right to purchase a total of 75,000 shares of Exelixis, Inc. common stock, became fully exercisable on February 11, 2020.